Thomas Civik - Net Worth and Insider Trading
Thomas Civik Net Worth
The estimated net worth of Thomas Civik is at least $94,650 dollars as of 2024-04-29. Thomas Civik is the Director of Pyxis Oncology Inc and owns about 15,700 shares of Pyxis Oncology Inc (PYXS) stock worth over $70,650. Thomas Civik is also the Director of Repare Therapeutics Inc and owns about 7,500 shares of Repare Therapeutics Inc (RPTX) stock worth over $24,000. Details can be seen in Thomas Civik's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Civik has not made any transactions after 2021-11-18 and currently still holds the listed stock(s).
Transaction Summary of Thomas Civik
Thomas Civik Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Civik owns 4 companies in total, including Five Prime Therapeutics Inc (FPRX) , Foundation Medicine Inc (FMI) , and Pyxis Oncology Inc (PYXS) among others .
Click here to see the complete history of Thomas Civik’s form 4 insider trades.
Insider Ownership Summary of Thomas Civik
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2020-04-13 | director & President and CEO |
| FMI | Foundation Medicine Inc | 2018-07-31 | Chief Commercial Officer |
| PYXS | Pyxis Oncology Inc | 2021-11-18 | director |
| RPTX | Repare Therapeutics Inc | 2021-11-16 | director |
Thomas Civik Latest Holdings Summary
Thomas Civik currently owns a total of 2 stocks. Among these stocks, Thomas Civik owns 15,700 shares of Pyxis Oncology Inc (PYXS) as of November 18, 2021, with a value of $70,650 and a weighting of 74.64%. Thomas Civik also owns 7,500 shares of Repare Therapeutics Inc (RPTX) as of November 16, 2021, with a value of $24,000 and a weighting of 25.36%.
Latest Holdings of Thomas Civik
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PYXS | Pyxis Oncology Inc | 2021-11-18 | 15,700 | 4.50 | 70,650 |
| RPTX | Repare Therapeutics Inc | 2021-11-16 | 7,500 | 3.20 | 24,000 |
Holding Weightings of Thomas Civik
Thomas Civik Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Civik has made a total of 1 transactions in Pyxis Oncology Inc (PYXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pyxis Oncology Inc is the acquisition of 15,700 shares on November 18, 2021, which cost Thomas Civik around $200,018.
According to the SEC Form 4 filings, Thomas Civik has made a total of 1 transactions in Repare Therapeutics Inc (RPTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Repare Therapeutics Inc is the acquisition of 7,500 shares on November 16, 2021, which cost Thomas Civik around $210,600.
Insider Trading History of Thomas Civik
- 1
Thomas Civik Trading Performance
GuruFocus tracks the stock performance after each of Thomas Civik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Civik is -46.1%. GuruFocus also compares Thomas Civik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Civik within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Civik's insider trading performs compared to the benchmark.
Performance of Thomas Civik
Average Return
-64.28%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -32.4 | -46.1 | -76.88 | -64.28 | -61.23 | |
| Relative Return to S&P 500(%) | -31.16 | -39.92 | -61.21 | -48.53 | -59.17 |
Thomas Civik Ownership Network
Ownership Network List of Thomas Civik
Ownership Network Relation of Thomas Civik
Thomas Civik Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Thomas Civik is the director & President and CEO of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and 10 percent owner Bvf Partners L P/il .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
Thomas Civik Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Civik. You might contact Thomas Civik via mailing address: C/o Foundation Medicine, Inc., 150 Second Street, Cambridge Ma 02141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
